Pfizer Medical Information

Health Care Professionals Log In

  Questions?

Submit Medical Question»

PatientEducationMaterial

SUTENT(R)  (sunitinib malate) Capsules Indication Statement SUTENT is indicated for the treatment of gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.


Gastrointestinal Stromal Tumor (GIST)


SUTENT.com
A Web site for patients and caregivers with information on SUTENT® (sunitinib malate), GIST,
and First Resource®, a comprehensive reimbursement support and patient assistance program
sponsored by Pfizer Oncology.

Understanding GIST, a cancer that affects the digestive system
This guide will help your patients understand GIST and provide information on its causes,
stages, and treatments.



When you click on an item, it will open in a new window.

download Adobe Acrobat Reader In order to view these PDF documents, you must have Adobe® Reader® installed
on your computer. If you do not have Adobe Reader, download it from the Adobe Web site.


Note that the Adobe Web site is neither owned nor controlled by Pfizer. Pfizer is not responsible for the content or services on that site.

Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated in the United States and/or other countries.